Texas Trial by Dr. Isabel Martinez
Presented by Martinez I, Horne B, Verdegem P. Lipid and glucose optimization using phytonutrient combination therapy in diabetes. in 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2007. Chicago.
Texas Trial by Dr. Isabel Martinez
Presented by Martinez I, Horne B, Verdegem P. Lipid and glucose optimization using phytonutrient combination therapy in diabetes. in 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2007. Chicago.
Original Title
HisWellness.com - BIOS SLIM - Texas Trial by Dr Isabel Martinez
Texas Trial by Dr. Isabel Martinez
Presented by Martinez I, Horne B, Verdegem P. Lipid and glucose optimization using phytonutrient combination therapy in diabetes. in 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2007. Chicago.
Texas Trial by Dr. Isabel Martinez
Presented by Martinez I, Horne B, Verdegem P. Lipid and glucose optimization using phytonutrient combination therapy in diabetes. in 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2007. Chicago.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PDF or read online from Scribd
Download as pdf
You are on page 1/ 1
Lipid and glucose optimization using phytonutrient combination
therapy in diabetes
Isabel Martinez, MD.1, Bobbi Horne1, Peter J.E. Verdegem, Ph.D., MBA2 1 Blue Mesa Medical Associates, Katy, TX, 2Unicity International, Orem, UT.
Introduction: Dietary approaches to management of lipid and glucose
parameters in diabetes is gaining popularity among patients. Monotherapy with dietary ingredients has shown positive effects, but with limited clinical relevance. Our research focuses on using a phytonutrient combination in optimizing lipid and glucose parameters. All four ingredients have individual data supporting their use for optimizing lipoprotein fractions in hypercholesterolemia. This pilot study evaluates their combined efficacy in type-II diabetes.
Methods: A group of 34 subjects with established type-II diabetes and
hypercholesterolemia added the product to their diet. The drink was taken thrice daily 15-20 minutes before meals. The fiber drink consists of viscous soluble fiber, minerals, vitamins, policosanol, phytosterols, and an aqueous Chrysanthemum morifolium extract. Lipid and glucose parameters were measured at baseline, 4 and 8 weeks.
Results: Parameter Inclusion B.L. t=8 ∆% p-value criteria at BL (mg/dL) weeks (mg(dL) (mg/dL) TC All 208 178 -14.2 <0.01 TC >200 245 195 -21.5 <0.001 LDL-c All 127 104 -18.3 <0.05 LDL-c >160 197 141 -28.9 <0.005 HDL-c All 46 48 +3.5 n.s. HDL-c <40 35 40 +14.4 n.s. TG All 182 143 -21.3 n.s. TG >150 242 163 -32.5 <0.05 Glu All 162 134 -17.3 <0.05 Glu >175 218 155 -28.9 <0.05 a a,b HbA1c All 7.2 6.6 -9.4 <0.05 HbA1c >8a 9.2a 7.8a,b -15.8 <0.05 a in %; bmeasurement at 12 weeks.
Conclusion: BiosLife, a phytonutrient combination drink, shows potential in
optimizing parameters associated with cardio vascular disease risk in type-II diabetes. These findings are well in line with previously reported clinical results. The fiber component has reduced the post-prandial glucose levels and the resulting lower HbA1c levels indicate that BiosLife provides a natural option to improve diabetes management.
2020 The Essential Diets - All Diets in One Book - Ketogenic, Mediterranean, Mayo, Zone Diet, High Protein, Vegetarian, Vegan, Detox, Paleo, Alkaline Diet and Much More: COOKBOOK, #2
